CD14+ HLA-DR low/- monocytes as indicator of disease aggressiveness in B-cell non-Hodgkin lymphoma

International Journal of Laboratory Hematology

Volumn 36, Issue 6, 2014, Pages 650-655

  Khalifa, K A ^a   Badawy, H M ^a   Radwan, W M ^a   Shehata, M A ^a   Bassuoni, M A ^a  

^a MENOUFIA UNIVERSITY   (Egypt)

Author keywords

CD14+ HLA DRlow monocytes; Lymphoma; Relapse refractory

Indexed keywords

ARGINASE 1; HLA DR ANTIGEN; ANTINEOPLASTIC AGENT; ARGINASE; ARGINASE I, HUMAN; CD14 ANTIGEN;

ADULT; AMINO ACID METABOLISM; ARTICLE; CANCER CLASSIFICATION; CANCER REGRESSION; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LARGE CELL LYMPHOMA; MALE; MONOCYTE; NONHODGKIN LYMPHOMA; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN BLOOD LEVEL; AGED; B LYMPHOCYTE; BLOOD; CASE CONTROL STUDY; FLOW CYTOMETRY; GENE EXPRESSION; GENETICS; IMMUNOPHENOTYPING; LYMPHOMA, NON-HODGKIN; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RECURRENT DISEASE;

ADULT; AGED; ANTIGENS, CD14; ANTINEOPLASTIC AGENTS; ARGINASE; B-LYMPHOCYTES; CASE-CONTROL STUDIES; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HLA-DR ANTIGENS; HUMANS; IMMUNOPHENOTYPING; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MONOCYTES; NEOPLASM STAGING; PROGNOSIS; RECURRENCE;

EID: 84911807106     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/ijlh.12203     Document Type: Article

References (22)

1. low/-monocytes in B-cell non-Hodgkin lymphoma. Blood 2011;117:872-81.
2. Gabrilovich DI, Ostrand-Rosenberg S, Bronte V. Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol 2012;12:253-68.
3. Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009;9:162-74.
4. Zhang B, Wang Z, Wu L, Zhang M, Li W, Ding J, Zhu J, Wei H, Zhao K. Circulating and tumor-infiltrating myeloid-derived suppressor cells in patients with colorectal carcinoma. PLoS ONE 2013;8:e57114.
5. low/-cells correlate with clinical cancer stage and pathological grade in patients with bladder carcinoma. J Int Med Res 2011;39:1381-91.
6. Serafini P, Mgebroff S, Noonan K, Borrello I. Myeloid-derived suppressor cells promote crosstolerance in B-cell lymphoma by expanding regulatory T cells. Cancer Res 2008;68:5439-49.
7. Lekkou A, Karakantza M, Mouzaki A, Kalfarentzos F, Gogos CA. Cytokine production and monocyte HLA-DR expression as predictors of outcome for patients with community-acquired severe infections. Clin Diagn Lab Immunol 2004;11:161-7.
8. Monneret G, Lepape A, Voirin N, Bohé J, Venet F, Debard AL, Thizy H, Bienvenu J, Gueyffier F, Vanhems P. Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock. Intensive Care Med 2006;32:1175-83.
9. Ho Y-P, Sheen IS, Chiu CT, Wu CS, Lin CY. A strong association between down-regulation of HLA-DR expression and the late mortality in patients with severe acute pancreatitis. Am J Gastroenterol 2006;101:1117-24.
10. Mentula P, Kylänpää-Bäck ML, Kemppainen E, Takala A, Jansson SE, Kautiainen H, Puolakkainen P, Haapiainen R, Repo H. Decreased HLA (human leukocyte antigen)- DR expression on peripheral blood monocytes predicts the development of organ failure in patients with acute pancreatitis. Clin Sci (Lond) 2003;105:409-17.
11. Antoniades CG, Berry PA, Davies ET, Hussain M, Bernal W, Vergani D, Wendon J. Reduced monocyte HLA-DR expression: a novel biomarker of disease severity and outcome in acetaminophen-induced acute liver failure. Hepatology 2006;44:34-43.
12. Filipazzi P, Valenti R, Huber V, Pilla L, Canese P, Iero M, Castelli C, Mariani L, Parmiani G, Rivoltini L. Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony stimulation factor-based antitumor vaccine. J Clin Oncol 2007;25:2546-53.
13. Hoechst B, Ormandy LA, Ballmaier M, Lehner F, Krüger C, Manns MP, Greten TF, Korangy F. A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4+CD25+Foxp3+ T cells. Gastroenterology 2008;135:234-43.
14. Luczynski W, Stasiak-Barmuta A, Krawczuk-Rybak M, Szymański M, Malinowska I, Mitura-Lesiuk M. Monocytes in children with leukemias and lymphomas: down-regulation of HLA and costimulatory molecules. Acta Biochim Pol 2004;51:1067-73.
15. Vuk-Pavlovic S, Bulur PA, Lin Y, Qin R, Szumlanski CL, Zhao X, Dietz AB. Immunosuppressive CD14+HLA-DRlow/- monocytes in prostate cancer. Prostate 2010;70:443-55.
16. Gustafson MP, Lin Y, New KC, Bulur PA, O'Neill BP, Gastineau DA, Dietz AB. Systemic immune suppression in glioblastoma: the interplay between CD14+HLA-DRlow/neg monocytes, tumor factors, and dexamethasone. Neuro Oncol 2010;12:631-44.
17. Nagaraj S, Gabrilovich DI. Myeloid-derived suppressor cells. Adv Exp Med Biol 2007;601:213-23.
18. Ziegler-Heitbrock L. The CD14+CD16+ blood monocytes: their role in infection and inflammation. J Leukoc Biol 2007;81:584-92.
19. Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003;19:71-82.
20. Hoechst B, Voigtlaender T, Ormandy L, Gamrekelashvili J, Zhao F, Wedemeyer H, Lehner F, Manns MP, Greten TF, Korangy F. Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor. Hepatology 2009;50:799-807.
21. Wilcox RA, Feldman AL, Wada DA, Yang ZZ, Comfere NI, Dong H, Kwon ED, Novak AJ, Markovic SN, Pittelkow MR, Witzig TE, Ansell SM. B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders. Blood 2009;114:2149-58.
22. Bronte V, Serafini P, Mazzoni A, Segal DM, Zanovello P. L-arginine metabolism in myeloid cells controls T-lymphocyte functions. Trends Immunol 2003;24:301-5.